07 January 2022: Meta-Analysis
Efficacy and Safety of Light Therapy as a Home Treatment for Motor and Non-Motor Symptoms of Parkinson Disease: A Meta-Analysis
Wenjie Sun AE , Junqiang Yan AFG* , Jiannan Wu BC , Hongxia Ma BDDOI: 10.12659/MSM.935074
Med Sci Monit 2022; 28:e935074
Table 2 Equipment and relevant parameters of all studies used in LT.
| Study ID | Device | Exposure distance | Interventional protocol | Investigated parameters | |
|---|---|---|---|---|---|
| EXP | CON | ||||
| Videnovic 2017 | Sun Ray Sunbox SB-558 | 86.4 cm | 60 min/day,morning+evening (2-week, follow-up 2-week) | White light (10,000 lux) | Dim red light (200 lux) |
| Rutten 2016–2019 | light box (Brazil, Lumie, Cambridge UK) | 30 min/day,morning+evening (3-month, follow-up 6-month) | White light (10,000 lux) | Dim light (200 lux) | |
| Rutten 2019 | Spectramax light therapy device | 60 min/day, evening (6-month, follow-up 1-month) | Blue/green light | Polychromatic light (100 lux) | |
| Willis 2018 | light source containing fluorescent tubes | 0.8–1 m | 60 min/day, evening (2-week) | Polychromatic light (3,000 lux) | Dim red light (200 lux) |
| Raymackers 2019 | A portable head-mounted device (Luminette®, Lucimed SA,Villers-le-Bouillet, Belgium) | 45 min/day, morning (1-month, 2-week washout, 1-month) | Blue light | Oeange light (175 lux) | |